JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE® (tocilizumab-bavi) injection, for intravenous use, a biosimilar to ACTEMRA (tocilizumab). The approval expands TOFIDENCE indications

First end-to-end European chip manufacturing flow proven for aerospace, defense, IoT, consumer electronics and critical infrastructure DRESDEN, Germany & DELFT, Netherlands–(BUSINESS WIRE)–#ASIC—GlobalFoundries (GF) and Qualinx today announced the successful completion of the first fully European-based, end-to-end semiconductor manufacturing flow at

KDDI receives newly issued shares of Coincheck Group at $2.28 per share, an aggregate cash purchase price of $65 million, constituting 14.9% ownership of Coincheck Group’s outstanding ordinary shares AMSTERDAM–(BUSINESS WIRE)–Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”),

The expanded partnership adds Denmark, Finland, Norway and Sweden to GENESIS Pharma’s existing network of thirteen Southeast European markets. It grants rights for the commercialization of Alnylam’s RNAi therapeutics for serious cardiomyopathy conditions and rare genetic diseases. ATHENS, Greece–(BUSINESS WIRE)–GENESIS

Four million single cells from 200-plus donors capture human neuronal biology in tissue context, now accessible via the Chan Zuckerberg Initiative’s CZ CELLxGENE platform SAN FRANCISCO–(BUSINESS WIRE)–Crownlands, Inc., a company scaling the collection of living human neurons to generate molecular